Biograd Diagnostics Adopts Autoscribe Informatics’ Matrix Gemini LIMS

Published on: 
In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter, June 2022, Volume 17, Issue 6

Biograd Diagnostics has chosen the Matrix Gemini system by Autoscribe Informatics as its laboratory information management system for managing COVID-19 test samples.

BioGrad Diagnostics, a UK-based diagnostics company, has adopted the Matrix Gemini system from Autoscribe Informatics, a UK-based database management company, as its laboratory information management system (LIMS). BioGrad, which is also a COVID-19 testing laboratory, is focusing on fast turn-around of COVID-19 samples. It intends to manage client and sample data within the LIMS, driving automation and efficiency, the company said in a May 12, 2022 press release.

The company offers rapid, accurate antigen and polymerase chain reaction COVID-19 testing and has been analyzing an increasing number of home test kits posted directly to its lab. BioGrad has also opened several satellite collection sites including Manchester, Warrington, and Liverpool, in the United Kingdom, offering supervised Pre-Travel, Day 2, Day 8, and Test-to-Release testing services for UK travelers and international travelers coming to the UK.

BioGrad chose to replace its old management system with Matrix Gemini LIMS to enable it to better cope with the increasing volume of samples from the SARS-CoV-2 epidemic The new LIMS provides the flexibility to capture data and report that data to Public Health England (PHE) for test and trace purposes. Certificates of analysis are also created for clients to support the various types of testing offered for the UK market, including Fit-to-fly, Day2, Day 8, and Test-to-Release.


Source: Autoscribe Informatics